Promis Neurosciences enters $25M ATM offering agreement with BTIG

ProMIS Neurosciences Inc.

At-the-market offering up to $25M of common shares via BTIG as sales agent.
Commission of 3% of gross proceeds; shares sold on Nasdaq based on Company instructions.
No minimum sales requirement; Company controls timing and price of sales.
Offering effective Jan 5, 2024; shares issued under effective S-3 registration statement.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ProMIS Neurosciences Inc. entered into At The Market Offering Agreement with BTIG, LLC valued at up to $25.0 million (effective 2024-01-05).

Action: entry
Agreement: atm program
Counterparty: BTIG, LLC
Value: up to $25.0 million
Effective: 2024-01-05

Exact text from the filing

On January 5, 2024, Promis Neurosciences, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Agreement”) with BTIG, LLC, serving as agent (the “Agent”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, its common shares, no par value (the “Common Stock”), having an aggregate offering price of up to $25.0 million (the “Shares”) through the Agent (the “Offering”).

View on SEC.gov

197 material agreements filed in the last 30 days. Browse all material agreements →

ProMIS Neurosciences Inc. filing history →

Source: SEC EDGAR

accession 0001558370-24-000118

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.